URGN
UroGen Pharma (URGN)
$07
About UroGen Pharma (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$35.56
Daily low
$34.19
Price at open
$34.23
52 Week High
$35.56
52 Week Low
$12.73
Market cap
1.7B
Dividend yield
0.00%
Volume
325,927
Avg. volume
650,538
P/E ratio
-12.70
UroGen Pharma News
Details
Daily high
$35.56
Daily low
$34.19
Price at open
$34.23
52 Week High
$35.56
52 Week Low
$12.73
Market cap
1.7B
Dividend yield
0.00%
Volume
325,927
Avg. volume
650,538
P/E ratio
-12.70